Poland· PL-100440256
Gencebok
A caffeine product containing coffeini citras, registered in Poland by Gennisium Pharma. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Caffeine is registered in 15 of 19 countries.
Countries holding a registration under ATC N06BC01 (caffeine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Caffeine · ATC N06BC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Coffeini citras
- Manufacturer
- Gennisium Pharma
- Country
- Poland (PL)
- ATC code
- N06BC01
- ATC class
- Caffeine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin03770018587004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
86 interactions on record for caffeine.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Caffeine · interactions on record
86 records
- 5 severe
- 45 moderate
- 17 minor
- 18 info
Most severe, free to view
- TizanidineM03BX02severe
- EsketamineN01AX14severe
- CocaineN01BC01severe
- EsketamineN06AX27severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06BC01
Caffeine, as other registers publish it.
- United StatesAlertL.N.K. International, Inc.
- United StatesAlertTime Cap Labs, Inc
- United StatesAlertDOLGENCORP, LLC
- United StatesAlert AidAmerisource Bergen
- United StatesAlertness AidChain Drug Consortium
- United StatesAwakeWalgreen Company
- United StatesAwakeTopco Associates, LLC
- United StatesAwakeBetter Living Brands, LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3234019-1b74-486d-9ace-d63a10569d84 GET /v1/drugs/c3234019-1b74-486d-9ace-d63a10569d84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "03770018587004 ¦ Rpz ¦ EU/1/20/1465/001 ¦ 137431\n50 amp. 10 mg/ml",
"substance": "Coffeini citras 10 mg/ml",
"common_name": "Coffeini citras",
"pl_product_id": "100440256",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about caffeine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.